Skip to main content

Sovran Advisors, LLC

Position in GALT — Galectin Therapeutics Inc

CIK 2051471 SAN DIEGO, CA

Position in GALT

as of Mar 31, 2026 · filed May 1, 2026
Position Value
$719,345
-$220,290 QoQ
Shares Held
257,830
+14.1% QoQ
Ownership
0.392%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Sovran Advisors, LLC holds $5,991,448 across 3 Biotechnology names. GALT ranks #2 (12.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 GALT
Galectin Therapeutics Inc
This page
257,830 $719,345

All Filings in GALT

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $719,345 257,830
2025-12-31 $939,635 225,874
2025-09-30 $667,397 157,405
2025-06-30 $398,730 188,972
2025-03-31 $243,792 199,830
2024-12-31 $239,958 186,014